Plasma levels of EPA and DHA after ingestion of a single dose of EPA and DHA ethyl esters.

Autor: Schmieta HM; Institute of Food and One Health, Leibniz University Hannover, Hannover, Germany., Greupner T; Institute of Food and One Health, Leibniz University Hannover, Hannover, Germany., Schneider I; Institute of Food and One Health, Leibniz University Hannover, Hannover, Germany., Wrobel S; Food Chemistry, Faculty of Mathematics and Natural Sciences, University of Wuppertal, Wuppertal, Germany., Christa V; Food Chemistry, Faculty of Mathematics and Natural Sciences, University of Wuppertal, Wuppertal, Germany., Kutzner L; Food Chemistry, Faculty of Mathematics and Natural Sciences, University of Wuppertal, Wuppertal, Germany., Hahn A; Institute of Food and One Health, Leibniz University Hannover, Hannover, Germany., Harris WS; The Fatty Acid Research Institute, Sioux Falls, South Dakota, USA.; Department of Internal Medicine, Sanford School of Medicine, University of South Dakota, Sioux Falls, South Dakota, USA., Schebb NH; Food Chemistry, Faculty of Mathematics and Natural Sciences, University of Wuppertal, Wuppertal, Germany., Schuchardt JP; Institute of Food and One Health, Leibniz University Hannover, Hannover, Germany.; The Fatty Acid Research Institute, Sioux Falls, South Dakota, USA.
Jazyk: angličtina
Zdroj: Lipids [Lipids] 2024 Sep 19. Date of Electronic Publication: 2024 Sep 19.
DOI: 10.1002/lipd.12417
Abstrakt: Omega-3 polyunsaturated fatty acids (n3 PUFA), specifically eicosapentaenoic acid (EPA, 20:5n3), and docosahexaenoic acid (DHA, 22:6n3), are essential for maintaining health. To better understand their biology, it is important to define their bioavailability. The aim of this cross-over study was to investigate and compare the acute effects on plasma EPA and DHA levels after single doses of EPA oil (99% pure) and DHA (97% pure) ethyl esters. Twelve men aged 20-40 years with a body-mass-index of 20-27 kg/m 2 and low fish consumption were recruited. Several measures (e.g., 4-week run-in period, standardized diet, and blood collection protocols) were taken to reduce the inter-individual variability of plasma fatty acids levels. Using a cross-over design, the subjects received 2.2 g of EPA in the first test period and 2.3 g of DHA in the second. The test periods were separated by 2 weeks. Blood samples were taken before dosing and after 2, 4, 6, 8, 12, 24, 48, and 72 h. The mean ± SE maximum concentrations for EPA were higher than for DHA (115 ± 11 μg/mL vs. 86 ± 12 μg/mL; p = 0.05). The mean ± SE incremented area under the plasma concentration curve over 72 h for EPA (2461 ± 279 μg/mL) was 2.4 times higher (p < 0.001) than that for DHA (1021 ± 170 μg/mL). The mean ± SE half-life was for EPA and DHA was 45 ± 8 and 66 ± 12 h. Our results indicate that EPA administration in single doses leads to higher circulating plasma levels of EPA compared to an effect of an equivalent dose of DHA on DHA plasma levels.
(© 2024 The Author(s). Lipids published by Wiley Periodicals LLC on behalf of AOCS.)
Databáze: MEDLINE